Showing results (961-970 of 9,004) with videos related to
Sort By:
Pageof 901
European Journal of Clinical Pharmacology|January 1, 1982
Pharmacokinetics and biotransformation of the new benzodiazepine, lormetazepam, in man. III. Repeated administration and transfer to neonates via breast milkM Hümpel, I Stoppelli, S Milia, et al.European Journal of Clinical Pharmacology|January 1, 1983
Captopril combined with minoxidil, beta-blocker and furosemide in the treatment of refractory hypertensionY K Seedat, R RawatEuropean Journal of Clinical Pharmacology|January 1, 1983
Pharmacokinetics and absolute bioavailability of carteolol, a new beta-adrenergic receptor blocking agentT Ishizaki, A Ohnishi, T Sasaki, et al.European Journal of Clinical Pharmacology|January 1, 1984
Attenuation by diltiazem of arterial baroreflex sensitivity in manJ F Giudicelli, A Berdeaux, A Edouard, et al.European Journal of Clinical Pharmacology|January 1, 1984
Effects of fenflumizole on aggregation ex vivo of human platelets and formation of thromboxane B2 and 6-keto-prostaglandin-F1 alphaE Vinge, T Corell, K E AnderssonEuropean Journal of Clinical Pharmacology|January 1, 1984
Glibenclamide pharmacokinetics in acarbose-treated type 2 diabeticsJ Gerard, P J Lefebvre, A S LuyckxEuropean Journal of Clinical Pharmacology|January 1, 1983
The appropriate dosage regime for the transition from intravenous lignocaine to oral tocainide after acute myocardial infarctionJ W Upward, D Holt, P Emery, et al.European Journal of Clinical Pharmacology|January 1, 1983
Pharmacokinetics of tocainide in patients with combined hepatic and renal dysfunctionD Oltmanns, A Pottage, W EndellEuropean Journal of Clinical Pharmacology|January 1, 1982
Role of urinary alpha1-antitrypsin in Padutin (kallikrein) inactivationW H Hörl, R M Schäfer, A HeidlandEuropean Journal of Clinical Pharmacology|January 1, 1984
"Low T3-syndrome" in acute myocardial infarction--relationship to beta-adrenergic blockade and clinical courseF Pedersen, H Perrild, S L Rasmussen, et al.Pageof 901